Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | CA4 | P22748 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL924354 | 0.92 | CA1 (0.43) | CA1CA2CYP3A4TSHRNFKB1 | |
| SCHEMBL8748034 | 0.92 | CA1 (0.43) | CA1CA2CYP3A4TSHRNFKB1 | |
| SCHEMBL6918089 | 0.92 | — | — | |
| SCHEMBL7214773 | 0.92 | CA1 (0.43) | CA1CA2CYP3A4TSHRNFKB1 | |
| SCHEMBL6510515 | 0.92 | CA1 (0.43) | CA1CA2CYP3A4TSHRNFKB1 | |
| SCHEMBL25268289 | 0.92 | CA1 (0.43) | CA1CA2CYP3A4TSHRNFKB1 | |
| SCHEMBL3175118 | 0.92 | CA1 (0.43) | CA1CA2CYP3A4TSHRNFKB1 | |
| SCHEMBL5245802 | 0.92 | CA1 (0.43) | CA1CA2CYP3A4TSHRNFKB1 | |
| SCHEMBL9188051 | 0.92 | CA1 (0.43) | CA1CA2CYP3A4TSHRNFKB1 | |
| SCHEMBL3175115 | 0.92 | CA1 (0.43) | CA1CA2CYP3A4TSHRNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070352-A | Sustainable aviation fuel produced from normal alpha olefin byproducts and method thereof | 切弗朗菲利浦化学公司 | 2026-05-19 | — | — | CN | claimed |
| US-12540287-B2 | Sustainable aviation fuel from normal alpha olefin byproducts and process for same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-02-03 | — | — | US | claimed |
| WO-2025054258-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-03-13 | — | — | WO | claimed |
| US-20250084331-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-03-13 | — | — | US | claimed |
| CN-217093505-U | Process unit for producing chromium isobutyrate | 烟台远东精细化工有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-114716309-A | Process method and process device for producing chromium isobutyrate | 烟台远东精细化工有限公司 | 2022-07-08 | — | — | CN | claimed |
| EP-1560649-A4 | ACTIVE CATALYSTS FOR STEREOSELECTIVE RING-OPENING REACTIONS | RHODIA PHARMA SOLUTION INC (US) | 2007-05-02 | — | — | EP | claimed |
| EP-1560649-A1 | ACTIVE CATALYSTS FOR STEREOSELECTIVE RING-OPENING REACTIONS | Rhodia Pharma Solution Inc. (US) | 2005-08-10 | — | — | EP | claimed |
| US-6781006-B2 | Active catalysts for stereoselective ring-opening reactions | RHODIA PHARMA SOLUTIONS INC. | 2004-08-24 | — | — | US | claimed |
| WO-2004026469-A1 | ACTIVE CATALYSTS FOR STEREOSELECTIVE RING-OPENING REACTIONS | RHODIA PHARMA SOLUTIONS INC. (US) | 2004-04-01 | — | — | WO | claimed |
| US-20040053779-A1 | Active catalysts for stereoselective ring-opening reactions | SHASUN PHARMA SOLUTIONS, INC. | 2004-03-18 | — | — | US | claimed |
| CN-122070352-A | Sustainable aviation fuel produced from normal alpha olefin byproducts and method thereof | 切弗朗菲利浦化学公司 | 2026-05-19 | — | — | CN | disclosed |
| US-12618016-B2 | Methods for producing aviation fuels | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260103649-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2026-04-16 | — | — | US | disclosed |
| WO-2026043730-A1 | METHODS FOR PRODUCING AVIATION FUELS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-02-26 | — | — | WO | disclosed |
| EP-1560649-A4 | ACTIVE CATALYSTS FOR STEREOSELECTIVE RING-OPENING REACTIONS | RHODIA PHARMA SOLUTION INC (US) | 2007-05-02 | — | — | EP | disclosed |
| EP-1560649-A1 | ACTIVE CATALYSTS FOR STEREOSELECTIVE RING-OPENING REACTIONS | Rhodia Pharma Solution Inc. (US) | 2005-08-10 | — | — | EP | disclosed |
| US-6781006-B2 | Active catalysts for stereoselective ring-opening reactions | RHODIA PHARMA SOLUTIONS INC. | 2004-08-24 | — | — | US | disclosed |
| WO-2004026469-A1 | ACTIVE CATALYSTS FOR STEREOSELECTIVE RING-OPENING REACTIONS | RHODIA PHARMA SOLUTIONS INC. (US) | 2004-04-01 | — | — | WO | disclosed |
| US-20040053779-A1 | Active catalysts for stereoselective ring-opening reactions | SHASUN PHARMA SOLUTIONS, INC. | 2004-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618016-B2 | Methods for producing aviation fuels | CYP4F8, CYP8B1, CYP2E1 | CA1 3031/4885CA2 4079/4885CYP3A4 45/4885 |
| US-20250084331-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | ECH1, YAP1, ECHS1 | CA1 3635/4885CA2 4235/4885CYP3A4 33/4885 |
| US-20260103649-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | YAP1, CYP4F8, SCD | CA1 3025/4885CA2 3440/4885CYP3A4 111/4885 |
| US-12540287-B2 | Sustainable aviation fuel from normal alpha olefin byproducts and process for same | ADH1A, ADH1C, YAP1 | CA1 2758/4885CA2 3884/4885CYP3A4 94/4885 |
| US-20040053779-A1 | Active catalysts for stereoselective ring-opening reactions | CROCC, CA1, NBAS | CA1 2/4885CA2 82/4885CYP3A4 1048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.